Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMemorial Sloan Kettering Cancer Center
About this trial
This study is being done to find out how often endometrial cancer recurs after the standard treatment as well as how often the standard treatment results in a lymphedema.
Eligibility criteria
Qualifiers
ECOG performance status 0-1 or KPS ≥ 70%
Age ≥ 18 years
Endometrioid adenocarcinoma histologic diagnosis on endometrial biopsy or dilatation and curettage
No evidence of extrauterine disease, or suspicious pelvic lymph nodes, or distant metastases, or cervical invasion on pre-operative conventional imaging studies (Pelvic +/- Abdomen CT or MRI or sonogram, or body PET scan) and physical examination (uterine confined by exam and imaging )
Disqualifiers
Extrauterine disease, or gross lymph node involvement, or cervical invasion suspected on pre-operative imaging studies and physical examination (disease not uterine confined clinical stage > I)
Contraindication for SLN mapping
The planned treatment is not surgery, or the surgical treatment does not include hysterectomy in combination with SLN biopsy and a bilateral salpingo-oophorectomy
Hysterectomy
Trial design
Treatments tested in this trial
- Physical exam
Treatment groups
1,715 Participants
are divided into 2 treatment groupsLocations
19Czechia
Charles University and General University Hospital (Data Collection Only) Prague Czechia
Italy
OSPEDALE MICHELE E PIETRO (Data Collection Only) Ferrera Italy
UNIVERSITY OF MILANO-BICOCCA, ITALY (Data Collection) Milan Italy
FONDAZIONE POLICLINICOUNIVERSITARIO A. GEMELLI, ITALY (Data Collection Only) Roma Italy
Sponsors and collaborators
Memorial Sloan Kettering Cancer Center
Lead sponsor
Source ClinicalTrials.gov